U.S. Hospital Microbiology Testing Market Report 2016-2024

Nov 20, 2015, 12:10 ET from Research and Markets

DUBLIN, Nov. 20, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/43h3k6/2016_u_s) has announced the addition of the "2016 U.S. Hospital Microbiology Testing Market" report to their offering.

This new report contains 997 pages, 87 tables, and presents a comprehensive analysis of the US hospital microbiology testing market, including:

  • Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years
  • Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms
  • Volume and sales forecasts for 80 microbiology tests performed in US hospital laboratories
  • Instrumentation technologies and feature comparison of leading analyzers
  • Sales and market shares of leading suppliers by test
  • Emerging diagnostic technologies and their potential market applications
  • Product development opportunities
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies
  • Business opportunities and strategic recommendations for suppliers

Companies Mentioned

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreat

For more information visit http://www.researchandmarkets.com/research/43h3k6/2016_u_s

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets